Rosetta Genomics Begins Trading on Nasdaq

Feb 27, 2007

NEW YORK (GenomeWeb News) — Rosetta Genomics began trading on the New York Stock Exchange today at $7 per share with a total of 3.75 million shares.

The company’s bid price opened today at $7.02 and by mid-afternoon had climbed almost 7 percent to $7.50.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

DNA Tests Considered to Verify Relatedness at Border

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

First of 'Right to Try'

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

How Old Were They?

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

This Week in Nature

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

Main menu